CW May 2006
Volume 15Issue Number 5 May 2006 ISSN 10593802 Custom-Made Therapeutic Vaccine for CLL PatientsA custom-tailored vaccine is generated using specific protein from a patient?s own tumor to stimulate the natural immune system to destroy tumor cells. This is a type of active immunotherapy action that can last longer than passive immunotherapy.
Go to Previous Page Go to Next Page Source & Additional Reading For more information about the trial, patients can call Brandi O?Neal, Research Nurse, at 713-794-1518 or e-mail her at bloneal@mdanderson.org. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
